Nexigen GmbH

https://www.nexigen.de

Nexigen GmbH was set up in August 2007 by an interdisciplinary team of four scientists with the support of a business angel. Since 2002 the pre-seed phase has been supported as a successful spin-off project at the caesar research centre in Bonn. The start-up company Nexigen GmbH has specialised in innovative procedures for cellular screening systems for proteins and peptides. Patented technologies enable efficient development of innovative drug candidates which have minimal side effects for diseases which are difficult to treat. The proprietary technology platform is currently being used for their own therapeutic projects and co-operation with pharmaceutical companies. Projects with prestigious Top 20 pharmaceutical companies such as Bayer-Schering and Johnson & Johnson Pharmaceutical Research & Development, as well as with international biotech companies, have already been successfully carried out. The establishment of an own project pipeline initially aims to develop therapeutic peptides for the treatment of viral infections. *

	Start	2007-08-01 established
	Industry	peptide-based drug
	Industry 2	drug discovery
	Person	Vollmer, Jörg (Abalos Therapeutics 201910– CSO before Rigontec + Nexigen)
	Person 2	Hennemann, Hanjo (VeroVaccines GmbH 201707– Managing Direcotor + Co-Founder before Nexigen GmbH)

	Region	Köln (Cologne)
	Country	Germany
	Street	1 Nattermannallee
	City	50829 Köln
	Tel	+49-221-337772-00
		Address record changed: 2020-12-02

Basic data	Employees	B: 11 to 50 (2010-01-01)

		* Document for »About Section«:

		Record changed: 2023-12-30

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)